0002127436-26-000002.txt : 20260902 0002127436-26-000002.hdr.sgml : 20260902 20260901205003 ACCESSION NUMBER: 0002127436-26-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260902 DATE AS OF CHANGE: 20260901 EFFECTIVENESS DATE: 20260902 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Agen Genomics, Inc. CENTRAL INDEX KEY: 0002127436 ORGANIZATION NAME: EIN: 333110717 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-596137 FILM NUMBER: 261352451 BUSINESS ADDRESS: STREET 1: 1354 EMERAUDE GLN CITY: ESCONDIDO STATE: CA ZIP: 92029 BUSINESS PHONE: (949) 433-7831 MAIL ADDRESS: STREET 1: 1354 EMERAUDE GLN CITY: ESCONDIDO STATE: CA ZIP: 92029 D 1 primary_doc.xml X0708 D LIVE 0002127436 Agen Genomics, Inc. 1354 EMERAUDE GLN ESCONDIDO CA CALIFORNIA 92029 (949) 433-7831 CALIFORNIA None None Corporation true 2025 Christopher Scott Lippe 1354 Emeraude Gln Escondido CA CALIFORNIA 92029 Executive Officer Biotechnology $1 - $1,000,000 06b false 2026-08-28 true true false 25000 1500000 25000 1475000 false 0 0 0 25000 false Agen Genomics, Inc. Christopher Lippe Christopher Lippe CEO 2026-09-01